Prosecution Insights
Last updated: August 06, 2026

China Pharmaceutical University

4 pending office actions • 2 art units • 4 examiners • 0 of 4 (0%) have an AI response strategy ready • 5 patents granted in the last 365 days

Portfolio Summary

4
Total Pending OAs
3
Non-Final OAs
1
Final Rejections
0
Advisory / Quayle

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

3
Hard (75%)
0
Medium (0%)
1
Easy (25%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§101 + other1 (25%)
§112 only1 (25%)
Multi-statute (no §101)2 (50%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

2
Life Sciences
50% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
0
Mechanical / Eng
0% of docket
2
Business / Other
50% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

40 h
Manual time on pending OAs
8 h
Time saved (low, 20%)
14 h
Time saved (mid, 35%)
0.3 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
COUGHLIN, MATTHEW P 1 71.4% +11.9%
MCDOWELL, BRIAN E 1 74.2% +30.4%
MONTGOMERY, ANN Y 1 69.4% +27.1%
CANELLA, KAREN A 1 62.2% +32.8%

Hard Cases (3)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 3 ordered by deadline are shown.

App #TitleExaminerDue in
18757557 USE OF ENHANCER 3C1 IN PREPARATION OF ENHANCER FOR INTERACTION BETWEEN FXR AND CASPASE 8 COUGHLIN, MATTHEW P
18652809 SMALL MOLECULE COMPOUNDS TARGETING SRSF6 PROTEIN AND THEIR PREPARATION METHODS AND APPLICATIONS MCDOWELL, BRIAN E
17773492 METHOD FOR ANCHORING AND MODIFYING NANO-DRUG ON SURFACE OF LIVING CELL CANELLA, KAREN A

Interview Candidates (4)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 4 ordered by deadline are shown.

App #TitleExaminerDue in
18757557 USE OF ENHANCER 3C1 IN PREPARATION OF ENHANCER FOR INTERACTION BETWEEN FXR AND CASPASE 8 COUGHLIN, MATTHEW P
18652809 SMALL MOLECULE COMPOUNDS TARGETING SRSF6 PROTEIN AND THEIR PREPARATION METHODS AND APPLICATIONS MCDOWELL, BRIAN E
18570741 CELLULAR SENSORS BASED ON SURFACE-ENHANCED RAMAN SCATTERING AND APPLICATION THEREOF MONTGOMERY, ANN Y
17773492 METHOD FOR ANCHORING AND MODIFYING NANO-DRUG ON SURFACE OF LIVING CELL CANELLA, KAREN A

Top Art Units

Art UnitApps
1624 1
1643 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
18757557 USE OF ENHANCER 3C1 IN PREPARATION OF ENHANCER FOR INTERACTION BETWEEN FXR AND CASPASE 8 COUGHLIN, MATTHEW P §101§102§112 Non-Final OA Pending Jun 28, 2024
18652809 SMALL MOLECULE COMPOUNDS TARGETING SRSF6 PROTEIN AND THEIR PREPARATION METHODS AND APPLICATIONS MCDOWELL, BRIAN E 1624 §102§112 Non-Final OA Pending May 01, 2024
18570741 CELLULAR SENSORS BASED ON SURFACE-ENHANCED RAMAN SCATTERING AND APPLICATION THEREOF MONTGOMERY, ANN Y §112 Non-Final OA Pending Dec 15, 2023
17773492 METHOD FOR ANCHORING AND MODIFYING NANO-DRUG ON SURFACE OF LIVING CELL CANELLA, KAREN A 1643 §103§112 Final Rejection Pending Apr 29, 2022

Managing China Pharmaceutical University's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month